Table of Contents
The co-CEO of Ariel Investments and director of Ryan Specialty Holdings purchased 7,500 shares of the specialty insurance company at an average price of $35.16 per share, committing $263,700 of his own money at a time when Ryan Specialty's stock has fallen more than 54 percent over the past year. Following the transaction, Rogers directly holds 117,933 shares in the company, valued at approximately $4.1 million at the purchase price.
Rogers is no stranger to Ryan Specialty's boardroom. He has served as a director of the Chicago-based specialty insurance solutions provider since its 2021 initial public offering. His latest open-market purchase is the first reported insider buy he has made in the stock in over 18 months, making the timing and size of the transaction notable.
Ryan Specialty has had a difficult run. The company's share price has declined sharply over the past year, weighed down by broader insurance market pressures and investor concerns about the specialty segment. The one-year total return as of early June stood at negative 54 percent, one of the steeper declines among NYSE-listed financial services companies in that period.
Against that backdrop, Rogers' decision to add $263,700 worth of shares at $35.16 each carries a specific meaning. Open-market insider purchases, where a director or executive uses their own money to buy company stock on the open exchange rather than through options or grants, are among the clearest signals of insider confidence. Rogers is not alone. Ryan Specialty's own CFO purchased 6,300 shares on June 3 for approximately $200,000. The company has also authorized an additional $300 million in share repurchases, extending an existing buyback program that saw $260 million deployed in May alone.
Rogers built Ariel Investments on the principle of patient, value-oriented investing in undervalued small and mid-cap companies. Founded in 1983 with $10,000 of his own capital, Ariel has grown into one of the most significant Black-owned asset management firms in the United States, with more than $16 billion in assets under management.
His boardroom presence extends well beyond Ryan Specialty. Rogers serves as a director of McDonald's Corporation, where he holds approximately 88,600 shares worth over $25 million, and Aon PLC, where he holds approximately 38,143 shares valued at over $12 million. He also holds a directorship at Exelon Corporation. His total disclosed public equity holdings across these positions put his direct stock portfolio well above $40 million.
Ryan Specialty, for its part, continues to post solid operational results despite its share price decline. First-quarter revenue grew 15.2 percent year over year to $795.2 million, and adjusted earnings rose 21.2 percent to $130.7 million. Its underwriting management segment grew revenue by 38 percent in the first quarter alone. The company expects mid-single-digit revenue growth excluding acquisitions for the full year 2026.
Rogers' latest purchase suggests he believes the market has mispriced that operational strength. It is a bet consistent with everything Ariel Investments has stood for across four decades.
The intelligence satisfies curiosity. The paid briefings satisfy strategy.
Every Monday, Elite subscribers receive an Investor Memo breaking down the deal, the structure and the positioning behind the week's most consequential African wealth story - the kind of analysis that doesn't appear anywhere else.
Twice a month, a Wealth Intelligence brief profiles a single billionaire's holdings, cash flows and expansion pipeline in detail no public source matches.
→ Executive ($25/mo): Daily newsletter + Deep-Dive Reports
→ Elite ($75/mo): Everything above + Investor Memos + Wealth Intelligence + Quarterly Analyst Briefings
Subscribe now